CD274 and hepatocellular carcinoma: Inactivation of MYC has been found to downregulate PD-L1 mRNA and protein expression, enhancing the anti-tumor immune responses in tumor tissues such as hepatocellular carcinoma, acute T-lymphocytic leukemia, and melanoma [207].